In just 4 years, there’s been a significant evolution in the profile of pediatric and young adult patients who’ve taken the chimeric antigen receptor (CAR) T-cell […]

A new antibiotic uses a never-before-seen mechanism to deliver a direct hit on tough-to-treat infections while leaving beneficial microbes alone. The strategy could lead to a […]

LONG BEACH, California — A catheter-directed mechanical pulmonary embolism (PE) extraction system approved on April 4 by the US Food and Drug Administration (FDA) demonstrated an […]

June 6, 2024 — Scientists in the United Kingdom have pinpointed genetic factors that appear to drive inflammatory bowel disease, and laboratory experiments using existing drugs […]

NASHVILLE, TENNESSEE — Stress in patients with multiple sclerosis (MS) can have serious effects on quality of life, but there is some evidence that it could […]

WASHINGTON, DC — Microbiota-focused dietary therapy could improve disease outcomes and management of metabolic dysfunction-associated steatotic liver disease (MASLD), according to a study presented at the […]

NASHVILLE, Tennessee — In a multicenter collaboration, patients with multiple sclerosis (MS) who developed hypogammaglobulinemia (HGG) after treatment with ocrelizumab or ofatumumab were found to have […]

LONG BEACH, California — Because women are underrepresented in clinical trials evaluating endovascular therapy with stent implantation and bypass surgery for symptomatic femoropopliteal peripheral artery disease […]

MILAN — Fecal microbiota transplantation (FMT), also known as intestinal microbiota transplantation, significantly reduced recurrence of hepatic encephalopathy compared with placebo in patients with cirrhosis on […]